Hysterectomy Workup

1. Johns A. Supracervical versus total hysterectomy. Clin Obstet Gynecol. 1997 Dec. 40(4):903-13. [QxMD MEDLINE Link].

2. Lepine LA, Hillis SD, Marchbanks PA. Hysterectomy surveillance--United States, 1980-1993. Mor Mortal Wkly Rep CDC Surveill Summ. 1997 Aug 8. 46(4):1-15. [QxMD MEDLINE Link].

3. Zhao SZ, Wong JM, Arguelles LM. Hospitalization costs associated with leiomyoma. Clin Ther. 1999 Mar. 21(3):563-75. [QxMD MEDLINE Link].

4. Goodwin SC, Wong GC. Uterine artery embolization for uterine fibroids: a radiologist's perspective. Clin Obstet Gynecol. 2001 Jun. 44(2):412-24. [QxMD MEDLINE Link].

5. Kjerulff KH, Erickson BA, Langenberg PW. Chronic gynecological conditions reported by US women: findings from the National Health Interview Survey, 1984 to 1992. Am J Public Health. 1996 Feb. 86(2):195-9. [QxMD MEDLINE Link].

6. Guarnaccia MM, Rein MS. Traditional surgical approaches to uterine fibroids: abdominal myomectomy and hysterectomy. Clin Obstet Gynecol. 2001 Jun. 44(2):385-400. [QxMD MEDLINE Link].

7. Demello AB. Uterine artery embolization. AORN J. 2001 Apr. 73(4):790-2, 794-8, 800-4 passim; quiz 809-14. [QxMD MEDLINE Link].

8. Townsend DE, Sparkes RS, Baluda MC. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol. 1970 Aug 15. 107(8):1168-73. [QxMD MEDLINE Link].

9. Gross KL, Morton CC. Genetics and the development of fibroids. Clin Obstet Gynecol. 2001 Jun. 44(2):335-49. [QxMD MEDLINE Link].

10. Reiter RC, Gambone JC, Lench JB. Appropriateness of hysterectomies performed for multiple preoperative indications. Obstet Gynecol. 1992 Dec. 80(6):902-5. [QxMD MEDLINE Link].

11. Lee NC, Dicker RC, Rubin GL. Confirmation of the preoperative diagnoses for hysterectomy. Am J Obstet Gynecol. 1984 Oct 1. 150(3):283-7. [QxMD MEDLINE Link].

12. Weir E. The public health toll of endometriosis. CMAJ. 2001. 164(8):1201.

13. Greenlee RT, Murray T, Bolden S. Cancer statistics, 2000. CA Cancer J Clin. 2000 Jan-Feb. 50(1):7-33. [QxMD MEDLINE Link].

14. Duan L, Xu X, Koebnick C, Lacey JV Jr, Sullivan-Halley J, Templeman C, et al. Bilateral oophorectomy is not associated with increased mortality: the California Teachers Study. Fertil Steril. 2012 Jan. 97(1):111-7. [QxMD MEDLINE Link]. [Full Text].

15. Sawaya GF, Brown AD, Washington AE. Clinical practice. Current approaches to cervical-cancer screening. N Engl J Med. 2001 May 24. 344(21):1603-7. [QxMD MEDLINE Link].

16. Kovac SR. Which route for hysterectomy? Evidence-based outcomes guide selection. Postgrad Med. 1997 Sep. 102(3):153-8. [QxMD MEDLINE Link].

17. Mahnert N, Kamdar N, Lim CS, Skinner B, Hassett A, Kocher KE, et al. Risk Factors for Emergency Department Visits After Hysterectomy for Benign Disease. Obstet Gynecol. 2017 Aug. 130 (2):296-304. [QxMD MEDLINE Link].

18. Catro-Alves LJ, De Azevedo VL, De Freitas Braga TF, Goncalves AC, De Oliveira GS Jr. The effect of neuraxial versus general anesthesia techniques on postoperative quality of recovery and analgesia after abdominal hysterectomy: a prospective, randomized, controlled trial. Anesth Analg. 2011 Dec. 113(6):1480-6. [QxMD MEDLINE Link].

19. Gendy R, Walsh CA, Walsh SR, Karantanis E. Vaginal hysterectomy versus total laparoscopic hysterectomy for benign disease: a metaanalysis of randomized controlled trials. Am J Obstet Gynecol. 2011 Mar 3. [QxMD MEDLINE Link].

20. Lowes R. FDA Toughens Power Morcellation Warning. Medscape Medical News. Available at https://www.medscape.com/viewarticle/835375. November 24, 2014; Accessed: April 12, 2018.

21. Multinu F, Casarin J, Hanson KT, Angioni S, Mariani A, Habermann EB, et al. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation. JAMA Surg. 2018 Apr 11. e180141. [QxMD MEDLINE Link].

22. ACOG Committee Opinion No. 388 November 2007: supracervical hysterectomy. Obstet Gynecol. 2007 Nov. 110(5):1215-7. [QxMD MEDLINE Link].

23. ACOG Technology Assessment in Obstetrics and Gynecology No. 6: Robot-assisted surgery. Obstet Gynecol. 2009 Nov. 114(5):1153-5. [QxMD MEDLINE Link].

24. Kovac SR. Guidelines to determine the role of laparoscopically assisted vaginal hysterectomy. Am J Obstet Gynecol. 1998 Jun. 178(6):1257-63. [QxMD MEDLINE Link].

25. Gimbel H. Total or subtotal hysterectomy for benign uterine diseases? A meta-analysis. Acta Obstet Gynecol Scand. 2007. 86(2):133-44. [QxMD MEDLINE Link].

26. Johnson N, Barlow D, Lethaby A, Tavender E, Curr E, Garry R. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2006 Apr 19. CD003677. [QxMD MEDLINE Link].

27. Nieboer TE, Hendriks JC, Bongers MY, Vierhout ME, Kluivers KB. Quality of life after laparoscopic and abdominal hysterectomy: a randomized controlled trial. Obstet Gynecol. 2012 Jan. 119(1):85-91. [QxMD MEDLINE Link].

28. Charoenkwan K, Phillipson G, Vutyavanich T. Early versus delayed (traditional) oral fluids and food for reducing complications after major abdominal gynaecologic surgery. Cochrane Database Syst Rev. 2007 Oct 17. CD004508. [QxMD MEDLINE Link].

29. Gibson CJ, Thurston RC, El Khoudary SR, Sutton-Tyrrell K, Matthews KA. Body mass index following natural menopause and hysterectomy with and without bilateral oophorectomy. Int J Obes (Lond). 2012 Sep 25. [QxMD MEDLINE Link].

30. Hur HC, Donnellan N, Mansuria S, Barber RE, Guido R, Lee T. Vaginal cuff dehiscence after different modes of hysterectomy. Obstet Gynecol. 2011 Oct. 118(4):794-801. [QxMD MEDLINE Link].

31. Dessources K, Hou JY, Tergas AI, et al. Factors Associated With 30-Day Hospital Readmission After Hysterectomy. Obstet Gynecol. 2015 Jan 7. [QxMD MEDLINE Link].

32. Gupta JK, Sinha AS, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2006 Jan 25. CD005073. [QxMD MEDLINE Link].

33. Thakar R, Ayers S, Georgakapolou A, Clarkson P, Stanton S, Manyonda I. Hysterectomy improves quality of life and decreases psychiatric symptoms: a prospective and randomised comparison of total versus subtotal hysterectomy. BJOG. 2004 Oct. 111(10):1115-20. [QxMD MEDLINE Link].

34. Committee on Gynecologic Practice. Committee Opinion No 701: Choosing the Route of Hysterectomy for Benign Disease. Obstet Gynecol. 2017 Jun. 129 (6):e155-e159. [QxMD MEDLINE Link].

35. [Guideline] Chrysostomou A, Djokovic D, Edridge W, van Herendael BJ. Evidence-based practical guidelines of the International Society for Gynecologic Endoscopy (ISGE) for vaginal hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2020 Sep. 252:118-26. [QxMD MEDLINE Link]. [Full Text].

36. Farquhar CM, Naoom S, Steiner CA. The impact of endometrial ablation on hysterectomy rates in women with benign uterine conditions in the United States. Int J Technol Assess Health Care. 2002 Summer. 18(3):625-34. [QxMD MEDLINE Link].

37. Jacobson GF, Shaber RE, Armstrong MA, Hung YY. Hysterectomy rates for benign indications. Obstet Gynecol. 2006 Jun. 107(6):1278-83. [QxMD MEDLINE Link].

Hetal B Gor, MD, FACOG Obstetrician/Gynecologist, Private Practice

Hetal B Gor, MD, FACOG is a member of the following medical societies: American College of Obstetricians and Gynecologists, Society of Laparoendoscopic Surgeons

Disclosure: Nothing to disclose.

Michel E Rivlin, MD Former Professor, Department of Obstetrics and Gynecology, University of Mississippi School of Medicine

Michel E Rivlin, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, Mississippi State Medical Association, Royal College of Surgeons of Edinburgh, Royal College of Obstetricians and Gynaecologists

Disclosure: Nothing to disclose.

Gloria Bachmann, MD, Interim Chair, Department of Obstetrics, Gynecology and Reproductive Sciences, Associate Dean of Women's Health, Women's Health Institute; Chief of Obstetrics and Gynecology Service, Professor, Departments of Medicine and Obstetrics and Gynecology, Robert Wood Johnson University Hospital, University of Medicine and Dentistry of New Jersey

Disclosure: Wyeth Grant/research funds PI on research; Bayer; Grant/research funds PI on research; GSK Grant/research funds PI on research; Duramed Grant/research funds PI on research; Novartis Grant/research funds PI on research; Pfizer Grant/research funds PI on research; Boehringer-Ingelheim Grant/research funds PI on research; Johnson and Johnson Grant/research funds PI on research; Roche Grant/research funds PI on research; Boston Scientific Grant/research funds PI on research; Novo Nordisk Grant/research funds PI on research; Proctor and Gamble Grant/research funds PI on research; Merck Grant/research funds PI on research; Xanodyne Grant/research funds PI on research; Hormos Grant/research funds PI on research

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Reference Salary Employment

• Print this section
• Print the entire contents of
• Print the entire contents of article